EirGenix Revenue

EirGenix had revenue of 181.92M TWD in the quarter ending March 31, 2025, a decrease of -17.19%. This brings the company's revenue in the last twelve months to 971.19M, down -5.34% year-over-year. In the year 2024, EirGenix had annual revenue of 1.01B, down -1.34%.

Revenue (ttm)

971.19M

Revenue Growth

-5.34%

P/S Ratio

19.33

Revenue / Employee

971.19K

Employees

1,000

Market Cap

18.78B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	1.01B	-13.69M	-1.34%
Dec 31, 2023	1.02B	-458.36M	-30.95%
Dec 31, 2022	1.48B	-216.34M	-12.75%
Dec 31, 2021	1.70B	625.52M	58.36%
Dec 31, 2020	1.07B	595.75M	125.14%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
PharmaEssentia	11.34B
Caliway Biopharmaceuticals	40.47M
Bora Pharmaceuticals Co., LTD.	20.87B
Lotus Pharmaceutical	19.12B
Oneness Biotech	117.33M
Polaris Group	87.67M
Lumosa Therapeutics	43.59M
Center Laboratories	1.63B

Revenue Rankings